A Lesson to Learn o...
Health Care: Drugs
Perrigo Company (PRGO: NYSE)
$121.16 1.65 | 1.38%
06/18/13 - 04:04 PM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | 26.10 | 21.90 | 17.70 |
| P/E High - Last 5 Yrs | 30.10 | 51.70 | 67.70 |
| P/E Low - Last 5 Yrs | 10.80 | 14.80 | 12.50 |
| Beta | 0.69 | 1.02 | 0.98 |
| Price to Sales (TTM) | 3.35 | 2.69 | 1.42 |
| Price to Book (MRQ) | 5.12 | 5.54 | 2.41 |
| Price to Tangible Book (MRQ) | 72.36 | 16.21 | 5.08 |
| Price to Cash Flow (TTM) | 30.50 | 18.20 | 9.80 |
| Price to Free Cash Flow (TTM) | -77.40 | 53.90 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 0.30 | 0.70 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | 0.50 | 0.80 | 2.30 |
| Dividend 5 Yr Growth Rate (%) | 11.66 | 20.82 | 2.61 |
| Payout Ratio (TTM) | 7.00 | 14.00 | 37.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | 18.20 | 50.80 | -0.90 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | 15.20 | 18.40 | 2.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | 14.08 | -0.47 | 3.97 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | -3.30 | 32.40 | 18.70 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | -3.30 | 32.40 | 18.70 |
| EPS - 5 Yr Growth Rate (%) | 27.89 | 24.49 | 8.27 |
| Capital Spending - 5 Yr Growth Rate (%) | 34.02 | 0.56 | 4.03 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 1.40 | 1.50 | 1.10 |
| Current Ratio (MRQ) | 2.50 | 2.50 | 1.60 |
| LT Debt to Equity (MRQ) | 0.60 | 0.54 | 0.73 |
| Total Debt to Equity (MRQ) | 0.62 | 0.58 | 0.86 |
| Interest Coverage (TTM) | 6.80 | 17.50 | 6.40 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | 40.10 | 65.20 | 47.50 |
| Gross Margin - 5 Yr Avg | 36.50 | 62.50 | 46.90 |
| EBITD Margin (TTM) | 23.70 | 29.80 | 19.40 |
| EBITD - 5 Yr Avg | 17.02 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | 17.30 | 15.50 | 11.30 |
| Pre-Tax Margin - 5 Yr Avg | 13.80 | 11.30 | 10.10 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | 6.70 | 0.11 | 0.08 |
| Net Profit Margin - 5 Yr Avg | 10.30 | 7.80 | 7.00 |
| Return on Assets (TTM) | 5.10 | 11.10 | 3.10 |
| Return on Assets - 5 Yr Avg | 8.10 | 9.10 | 2.50 |
| Return on Investment (TTM) | 6.40 | 15.40 | 8.20 |
| Return on Investment - 5 Yr Avg | 11.10 | 13.30 | 6.60 |
| Efficiency | |||
| Revenue/Employee (TTM) | 386,859.00 | n.a. | n.a. |
| Net Income/Employee (TTM) | 25,865.00 | n.a. | n.a. |
| Receivable Turnover (TTM) | 5.70 | 11.10 | 7.90 |
| Inventory Turnover (TTM) | 3.20 | 2.50 | 7.70 |
| Asset Turnover (TTM) | 0.80 | 1.20 | 0.40 |
Portfolios with PRGO
- Portfolio NameUser Type
- ProRuane Cunniff
- ProNavellier & Associates
- ContributorTechnical Setups for the We...
- UserPardini´s Portfolio
- ContributorMost-Searched Stocks for th...
- ContributorRocket Stocks for the Week ...
- Contributor8 Pharma Stocks to Watch
- Contributor8 Health Care Stocks Inside...
- ProEdward Owens
- ContributorCramer's Stocks Worth Holdi...
Latest PRGO Headlines from TheStreet
- Perrigo Stock Hits New 52-Week High (PRGO) 04.02.13 | 12:04 pm
- Perrigo Company (PRGO): Today's Featured Health Care Laggard 03.07.13 | 05:03 pm
- Perrigo Stock To Go Ex-dividend Tomorrow (PRGO) 02.26.13 | 09:02 am
- Cramer's 6 Stocks in 60 Seconds: SBAC BLK IP SAP ZNGA PRGO (Update 1) 02.25.13 | 05:02 pm
- Perrigo Company (PRGO): Today's Featured Drugs Winner 02.25.13 | 05:02 pm
- 4 Stocks Pushing The Drugs Industry Higher 02.25.13 | 12:02 pm
- Perrigo Company (PRGO): Today's Featured Drugs Winner 02.11.13 | 05:02 pm
- Perrigo Rises On Unusually High Volume (PRGO) 02.01.13 | 12:02 pm
- Perrigo Company (PRGO): Today's Featured Health Care Winner 01.31.13 | 05:01 pm
- Perrigo Company (PRGO): Today's Featured Health Care Laggard 01.24.13 | 05:01 pm
Press Releases for PRGO
- Perrigo Acquisition Of Velcera, Inc. -- Known For Its PetArmor® Franchise Of Flea And Tick Treatments -- Closes Today - PR Newswire 04.01.13 | 10:04 am
- Perrigo Company Closes Acquisition Of Companion Animal Health Company, Velcera, Inc. - PR Newswire 04.01.13 | 09:04 am
- The Pomerantz Firm, Glancy Binkow & Goldberg LLP, And Robbins Geller Rudman & Dowd LLP Announce The Notice Of Proposed Settlement Of The In Re: Perrigo Company Securities Litigation - PR Newswire 03.22.13 | 09:03 am
- Perrigo To Begin Shipments Of Guaifenesin Extended-Release 600mg Tablets, The First Store Brand Equivalents To Mucinex® 600mg Extended Release Tablets - PR Newswire 03.18.13 | 09:03 am
- Perrigo Company To Present At The Barclays Global Healthcare Conference - PR Newswire 03.11.13 | 11:03 am
- Perrigo Company To Present At The RBC Global Healthcare Conference - PR Newswire 02.25.13 | 02:02 pm
- Perrigo Confirms First To File Patent Challenge For Generic Version Of Testosterone Gel 1.62% - PR Newswire 02.19.13 | 09:02 am
- Perrigo Company To Present At The Leerink Swann Global Healthcare Conference - PR Newswire 02.12.13 | 11:02 am
- Perrigo Confirms FDA Approval For Testosterone Gel 1% - PR Newswire 02.05.13 | 01:02 pm
- Perrigo Commences Launch Of Clobetasol Emulsion Propionate Foam, 0.05% - PR Newswire 02.01.13 | 07:02 am
Partner Headlines for PRGO
- Stocks Mixed Near Midday; Dillard's, 3D Systems Down - Investor's Business Daily 02.25.13 | 12:02 pm
- Perrigo expands UK presence - Financial Times 02.11.13 | 05:02 pm
- 106 Dividend Champions For December - Seeking Alpha 12.01.12 | 06:12 am
- Stocks Slide On Fiscal Cliff Worries; Retailers Hit - Investor's Business Daily 11.08.12 | 05:11 pm
- Stocks Plunge As Volume Surges - Investor's Business Daily 11.07.12 | 04:11 pm
- Stocks Stay In Deep Red; Whole Foods Reports After Close - Investor's Business Daily 11.07.12 | 02:11 pm
- Stocks Dive In Post-Election Riptide; Hospitals Rise - Investor's Business Daily 11.07.12 | 10:11 am
- Encouraging News for Perrigo - Analyst Blog - Zacks 10.18.12 | 07:10 pm
- Perrigo Seeks Generic Approval - Analyst Blog - NASDAQ 09.10.12 | 02:09 pm
- Perrigo Seeks Generic Approval - Analyst Blog - Zacks 09.10.12 | 10:09 am
